The Antiplatelet Activity of Danggijakyaksan by Inhibition of Phospholipase C

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 4, 2003, Pages 561-571

  Park, Won Hwan ^a,b   Kim, Seog Ha ^a,b   Chang, Young Chae ^c   Lee, Young Choon ^d   Kim, Cheorl Ho ^a,b  

^a Dongguk University   (South Korea)

^b Ministry of Science and Technology   (South Korea)

^c Keimyung University School of Medicine   (South Korea)

^d Dong A University   (South Korea)

Author keywords

3H inositol monophosphate; Antiplatelet activity; Aspirin treated platelet microsome; Collagen activated platelet; Danggijakyaksan (DJS); Korean herbal medicine; Nitric oxide (NO); Phospholipase C; Platelet aggregation; Thromboxane synthetase

Indexed keywords

ACETYLSALICYLIC ACID; ALISMATIS RHIZOMA EXTRACT; ANGELICA SINENSIS EXTRACT; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; ATRACTYLODES EXTRACT; CNIDIUM RHIZOME; COLLAGEN; DANGGIJAKYAKSAN; INOSITOL PHOSPHATE; NITRIC OXIDE; PAEONIA RADIX; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PORIA COCOS EXTRACT; THROMBOXANE SYNTHASE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; MICROSOME; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ARACHIDONIC ACID; BLOOD PLATELETS; COLLAGEN; HUMANS; NITRIC OXIDE; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C; PLANT EXTRACTS; PLATELET AGGREGATION INHIBITORS; THROMBOXANE-A SYNTHASE;

ANGELICA SINENSIS; ATRACTYLODES; CNIDIUM; COCOS; PAEONIA; PORIA COCOS;

EID: 0344736839     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120026441     Document Type: Article

References (23)

1. Li, S.C.; Pen-Tsao Kang, Mu. (republished by National Research Institute of Chinese Medicine, Taipei, 1976) 32, 1064, 1596.
2. Chang, H.M.; But, P.P.H. Pharmacology and Applications of Chinese Materials Medica. Vol. I; World Scientific Publishing Co. Pte. Ltd: Singapore, 1987; 605 pp.
3. Fujii, O.; Kanai, T.; Kouzuma, S.; Baba, K.; Miki, A.; Hyodo, H.; Yamashita, T.; Unno, N.; Taketani, Y. Herbal medicines, Sairei-to and Tokishakuyaku-san, differently modulate the release of cytokines from decidual versus peripheral blood mononuclear cells. Am. J. Reprod. Immunol. 2001, 46, 369-372.
4. Tagaya, E.; Tamaoki, J.; Kawatani, K.; Taira, M.; Nagai, A. Inhibition of airway smooth muscle tone by Chinese herbal medicines. Eur. Resp. J. 2000, 16, 1123-1128.
5. Sheu, J.R.; Hung, W.C.; Lee, Y.M.; Yen, M.H. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isloated from Evodia rutaecarpa. Eur. J. Pharmacol. 1996, 318, 469-475.
6. Zhou, Q.; Hellermann, G.R.; Solomonson, L.P. Nitric oxide release from resting human platelets. Thromb. Res. 1995, 77, 87-96.
7. Huang, T.F.; Sheu, J.R.; Teng, C.M. A potent antiplatelet peptide, triflavin, from trimeresurus flavoviridis snake venom. Biochem. J. 1991, 277, 351-357.
8. 3H]arachidonic from human platelets stimulated by thrombin or collagen. Thromb. Haemost. 1994, 72, 634-642.
9. Neylon, C.B.; Summers, R.J. Stimulation of 1-adrenoceptors in rat kidney mediates increased inositol phospholipid hydrolysis. Br. J. Pharmacol. 1987, 91, 363-376.
10. Lowry, D.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
11. Radomski, M.W.; Palmer, R.M.J.; Moncada, S. The anti-aggregating properties of vascular endothelium interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 1987, 92, 639-646.
12. Salvemini, D.; DeNucci, G.; Gryglewski, R.J.; Van, J.R. Human neutrophils and mononuclear cells inhibits platelet aggregation by releasing a nitric oxide-like factor. Proc. Natl. Acad. Sci. USA 1989, 86, 6328-6332.
13. Mollace, V.; Salvemini, D.; Anggard, E.; Vane, J. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br. J. Pharmacol. 1991, 104, 633-639.
14. Metha, J.L.; Chen, L.Y.; Kone, B.C.; Mehta, J.F.; Turner, P. Identification of constitute and inducible forms of nitric oxide synthase in human platelets. J. Lab. Clin. Med. 1995, 125, 370-377.
15. Kim, S.H. Anti-Platelet Effect Of The DJS, A Traditional Korean Medicine, By Thromboxane B2 Synthetase Inhibition. Dongguk University Graduate School, Kyungju, Korea, 2002; A Thesis of Degree of Master.
16. Nozawa, Y.; Nakasgima, S.; Nagata, K. Phospholipid-mediated signalling in receptor activation of human platelets. Biochim. Biophys. Acta 1991, 1082, 219-238.
17. Lloret, S.; Moreno, J.J. In vitro and in vivo effects of the anti inflammatory peptides, antiflammins. Biochem. Pharmacol. 1992, 44, 37-41.
18. Broekman, M.J.; Ward, J.W.; Marcus, A.J. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidyl inositol, phosphatic acid and lysophospholipids. J. Clin. Invest. 1980, 66, 275-283.
19. Mene, P.; Dunn, M.J. Prostaglandins and rat glomerular mesangial cell proliferation. Kidney Int. 1990, 37, 1256-1262.
20. Radomski, M.W.; Palmer, R.M.J.; Moncada, S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br. J. Pharmacol. 1990, 101, 325-328.
21. Berridge, M.J. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidyl-inositol. Biochem. J. 1983, 212, 849-858.
22. Bell, R.L.; Kennerly, D.A.; Stanford, N.; Majerus, P.W. Diglyceride lipase: a pathway for arachidonic acid release from human platelets. Proc. Natl. Acad. Sci. USA 1979, 76, 3241-3258.
23. Mckean, M.L.; Smith, J.B.; Silver, W.J. Formation of lysophosphatidylcholine in human platelets in response to thrombin. J. Biol. Chem. 1981, 256, 1522-1524.